Xie, Y., Wu, S., Zhang, Y., Li, J., Mo, M., Shao, Z., & Liu, G. (2021). Optimal Duration of Neoadjuvant Taxane and Carboplatin Combined With Anti-HER2 Targeted Therapy for HER2-Positive Breast Cancer. Front Oncol.
シカゴスタイル引用形Xie, Yifan, Siyu Wu, Ying Zhang, Jianwei Li, Miao Mo, Zhimin Shao, , Guangyu Liu. "Optimal Duration of Neoadjuvant Taxane and Carboplatin Combined With Anti-HER2 Targeted Therapy for HER2-Positive Breast Cancer." Front Oncol 2021.
MLA引用形式Xie, Yifan, et al. "Optimal Duration of Neoadjuvant Taxane and Carboplatin Combined With Anti-HER2 Targeted Therapy for HER2-Positive Breast Cancer." Front Oncol 2021.
警告: この引用は必ずしも正確ではありません.